Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate

FDA Drug Profile — Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate, PHOSPHA 250 NEUTRAL

Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate, PHOSPHA 250 NEUTRAL. Available dosage form: tablet.

Drug details

Generic Name
Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate
Brand Names
Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate, PHOSPHA 250 NEUTRAL
Sponsor
Rising Pharma Holdings, Inc.
NDC Codes
2
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Indications and Usage

INDICATIONS AND USAGE PHOSPHA 250 TM NEUTRAL increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S. RDA) of phosphorus for adults and children over 4 years of age.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.